Hunter C. Smith - 12 Nov 2021 Form 3 Insider Report for Aeglea BioTherapeutics, Inc. (AGLE)

Role
Director
Signature
/s/ Steven Weber, by power of attorney
Issuer symbol
AGLE
Transactions as of
12 Nov 2021
Transactions value $
$0
Form type
3
Filing time
16 Nov 2021, 15:32:59 UTC
Next filing
11 Feb 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney. No securities are beneficially owned.